Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference

Purpose: To evaluate the performance of radiomic features (RF) derived from PSMA PET for intraprostatic tumor discrimination and non-invasive characterization of Gleason score (GS) and pelvic lymph node status. Patients and methods: Patients with prostate cancer (PCa) who underwent [68Ga]-PSMA-11 PET/CT followed by radical prostatectomy and pelvic lymph node dissection were prospectively enrolled (n=20). Coregistered histopathological gross tumor volume (GTV-Histo) in the prostate served as reference. 133 RF were derived from GTV-Histo and from manually created segmentations of the intraprostatic tumor volume (GTV-Exp). Spearman´s correlation coefficients (ρ) were assessed between RF derived from the different GTVs. We additionally analyzed the differences in RF values for PCa and non-PCa tissues. Furthermore, areas under receiver-operating characteristics curves (AUC) were calculated and uni- and multivariate analyses were performed to evaluate the RF based discrimination of GS 7 and ≥8 disease and of patients with nodal spread (pN1) and non-nodal spread (pN0) in surgical specimen. The results found in the latter analyses were validated by a retrospective cohort of 40 patients. Results: Most RF from GTV-Exp showed strong correlations with RF from GTV-Histo (86% with ρ>0.7). 81% and 76% of RF from GTV-Exp and GTV-Histo significantly discriminated between PCa and non-PCa tissue. The texture feature QSZHGE discriminated between GS 7 and ≥8 considering GTV-Histo (AUC=0.93) and GTV-Exp (prospective cohort: AUC=0.91 / validation cohort: AUC=0.84). QSZHGE also discriminated between pN1 and pN0 disease considering GTV-Histo (AUC=0.85) and GTV-Exp (prospective cohort: AUC=0.87 / validation cohort: AUC=0.85). In uni- and multivariate analyses including patients of both cohorts QSZHGE was a statistically significant (p<0.01) predictor for PCa patients with GS ≥8 tumors and pN1 status. Conclusion: RF derived from PSMA PET discriminated between PCa and non-PCa tissue within the prostate. Additionally, the texture feature QSZHGE discriminated between GS 7 and GS ≥8 tumors and between patients with pN1 and pN0 disease. Our results support the role of RF in PSMA PET as a new tool for non-invasive PCa discrimination and characterization of its biological properties.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  M. Hatt,et al.  Responsible Radiomics Research for Faster Clinical Translation , 2017, The Journal of Nuclear Medicine.

[3]  Tobias Fechter,et al.  3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study , 2013, Radiation oncology.

[4]  Robert King,et al.  Textural features corresponding to textural properties , 1989, IEEE Trans. Syst. Man Cybern..

[5]  M. Schwaiger,et al.  The Sensitivity of [11C]Choline PET/CT to Localize Prostate Cancer Depends on the Tumor Configuration , 2011, Clinical Cancer Research.

[6]  J. E. van Timmeren,et al.  Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Seymour Rosen,et al.  Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. , 2003, The Journal of urology.

[8]  Karin Haustermans,et al.  Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  J. Quian,et al.  Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. , 2004, Histology and histopathology.

[10]  Issam El-Naqa,et al.  Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..

[11]  M. Bock,et al.  Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference , 2018, Radiation oncology.

[12]  I. Thompson,et al.  Current status of lymph node‐positive prostate cancer , 2006, Cancer.

[13]  D. Jäger,et al.  Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer , 2018, Scientific Reports.

[14]  Robert J. Gillies,et al.  The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis , 2015, Scientific Reports.

[15]  Dan Stoianovici,et al.  Advancements in MR imaging of the prostate: from diagnosis to interventions. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[16]  Slave Trajanoski,et al.  Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis , 2009, Pathology & Oncology Research.

[17]  M. Allaf,et al.  Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer , 2018, Current opinion in urology.

[18]  Jacob D. Furst,et al.  RUN-LENGTH ENCODING FOR VOLUMETRIC TEXTURE , 2004 .

[19]  G. Mohapatra,et al.  Tumor necrosis in radical prostatectomies with high-grade prostate cancer is associated with multiple poor prognostic features and a high prevalence of residual disease. , 2017, Human pathology.

[20]  M. Bock,et al.  Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology , 2017, Theranostics.

[21]  M. Hatt,et al.  Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.

[22]  M. Schemper,et al.  A solution to the problem of separation in logistic regression , 2002, Statistics in medicine.

[23]  Milan Sonka,et al.  3D Slicer as an image computing platform for the Quantitative Imaging Network. , 2012, Magnetic resonance imaging.

[24]  A. Haese*,et al.  Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer. , 2018, European urology.

[25]  M. Schwaiger,et al.  Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. , 2016, The Journal of urology.

[26]  J. Yaxley,et al.  Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  R. Gillies,et al.  Repeatability and Reproducibility of Radiomic Features: A Systematic Review , 2018, International journal of radiation oncology, biology, physics.

[28]  L. Martí-Bonmatí,et al.  Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method , 2017, Physics in medicine and biology.

[29]  Irène Buvat,et al.  Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis , 2014, The Journal of Nuclear Medicine.

[30]  James F. Greenleaf,et al.  Use of gray value distribution of run lengths for texture analysis , 1990, Pattern Recognit. Lett..

[31]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[32]  Marco Nolden,et al.  The Medical Imaging Interaction Toolkit , 2005, Medical Image Anal..

[33]  Peter Wust,et al.  PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives , 2018, Radiation Oncology.

[34]  K. Rahbar,et al.  Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer , 2016, The Journal of Nuclear Medicine.

[35]  A. Gelman.  Scaling regression inputs by dividing by two standard deviations , 2008, Statistics in medicine.

[36]  H. Hricak,et al.  Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores , 2015, European Radiology.

[37]  P. Stricker,et al.  Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer , 2017, BJU international.

[38]  M. Hatt,et al.  18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort , 2015, The Journal of Nuclear Medicine.

[39]  U. Capitanio,et al.  Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. , 2012, European urology.

[40]  E. Adang,et al.  The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. , 2008, Clinical radiology.

[41]  H. Ozen,et al.  Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. , 2007, Urologic oncology.

[42]  Dimitris Visvikis,et al.  Characterization of PET/CT images using texture analysis: the past, the present… any future? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  H Ballentine Carter,et al.  Complications after prostate biopsy: data from SEER-Medicare. , 2011, The Journal of urology.

[44]  El Naqa,et al.  A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities , 2015 .

[45]  M. Bock,et al.  PO-0818: Focal IMRT dose escalation for prostate cancer using PSMA PET/CT and MRI: a planning study , 2018 .

[46]  PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis , 2018, Scientific Reports.

[47]  R. Bundschuh,et al.  68Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  M. Schwaiger,et al.  Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. , 2016, European urology.

[49]  D Baltas,et al.  Significance of the impact of motion compensation on the variability of PET image features , 2018, Physics in medicine and biology.

[50]  Oscar Acosta,et al.  Haralick textural features on T2‐weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer , 2017, Journal of magnetic resonance imaging : JMRI.

[51]  C. Zamboglou,et al.  68Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison , 2016, Theranostics.

[52]  J. Karp,et al.  Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.